New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer

被引:41
作者
Conteduca, Vincenza [1 ]
Mosca, Alessandra [2 ]
Brighi, Nicole [1 ]
de Giorgi, Ugo [1 ]
Rescigno, Pasquale [3 ]
机构
[1] Ist Sci Romagnolo Studio Cura Tumori IRST, Dept Med Oncol, IRCCS, I-47014 Meldola, Italy
[2] FPO IRCCS, Candiolo Canc Inst, Multidisciplinary Outpatient Oncol Clin, I-10060 Turin, Italy
[3] FPO IRCCS, Candiolo Canc Inst, Interdisciplinary Grp Translat Res & Clin Trials, Urol Canc GIRT Uro, I-10060 Turin, Italy
关键词
prostate cancer; androgen receptor; PTEN; DNA repair defects; prognostic biomarkers; ANDROGEN RECEPTOR; DNA-REPAIR; INCREASED SURVIVAL; ENZALUTAMIDE; ABIRATERONE; MUTATIONS; PTEN; MEN; EXPRESSION; LETHAL;
D O I
10.3390/cells10010193
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Prostate cancer is one of the most frequent cancers in men and is a common cause of cancer-related death. Despite significant progress in the diagnosis and treatment of this tumor, patients who relapse after radical treatments inevitably develop metastatic disease. Patient stratification is therefore key in this type of cancer, and there is an urgent need for prognostic biomarkers that can define patients' risk of cancer-related death. In the last 10 years, multiple prognostic factors have been identified and studied. Here, we review the literature available and discuss the most common aberrant genomic pathways in metastatic castration-resistant prostate cancer shown to have a prognostic relevance in this setting.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 94 条
[1]   Genomic correlates of clinical outcome in advanced prostate cancer [J].
Abida, Wassim ;
Cyrta, Joanna ;
Heller, Glenn ;
Prandi, Davide ;
Armenia, Joshua ;
Coleman, Ilsa ;
Cieslik, Marcin ;
Benelli, Matteo ;
Robinson, Dan ;
Van Allen, Eliezer M. ;
Sboner, Andrea ;
Fedrizzi, Tarcisio ;
Mosquera, Juan Miguel ;
Robinson, Brian D. ;
De Sarkar, Navonil ;
Kunju, Lakshmi P. ;
Tomlins, Scott ;
Wu, Yi Mi ;
Rodrigues, Daniel Nava ;
Loda, Massimo ;
Gopalan, Anuradha ;
Reuter, Victor E. ;
Pritchard, Colin C. ;
Mateo, Joaquin ;
Bianchini, Diletta ;
Miranda, Susana ;
Carreira, Suzanne ;
Rescigno, Pasquale ;
Filipenko, Julie ;
Vinson, Jacob ;
Montgomery, Robert B. ;
Beltran, Himisha ;
Heath, Elisabeth I. ;
Scher, Howard I. ;
Kantoff, Philip W. ;
Taplin, Mary-Ellen ;
Schultz, Nikolaus ;
deBono, Johann S. ;
Demichelis, Francesca ;
Nelson, Peter S. ;
Rubin, Mark A. ;
Chinnaiyan, Arul M. ;
Sawyers, Charles L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (23) :11428-11436
[2]   Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer [J].
Agoulnik, Irina U. ;
Vaid, Ajula ;
Nakka, Manjula ;
Alvarado, Misty ;
Bingman, William E., III ;
Erdem, Halime ;
Frolov, Anna ;
Smith, Carolyn L. ;
Ayala, Gustavo E. ;
Ittmann, Michael M. ;
Weigel, Nancy L. .
CANCER RESEARCH, 2006, 66 (21) :10594-10602
[3]   Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression [J].
Agoulnik, IU ;
Vaid, A ;
Bingman, WE ;
Erdeme, H ;
Frolov, A ;
Smith, CL ;
Ayala, G ;
Ittmann, MM ;
Weigel, NL .
CANCER RESEARCH, 2005, 65 (17) :7959-7967
[4]   Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer [J].
Annala, Matti ;
Vandekerkhove, Gillian ;
Khalaf, Daniel ;
Taavitsainen, Sinja ;
Beja, Kevin ;
Warner, Evan W. ;
Sunderland, Katherine ;
Kollmannsberger, Christian ;
Eigl, Bernhard J. ;
Finch, Daygen ;
Oja, Conrad D. ;
Vergidis, Joanna ;
Zulfiqar, Muhammad ;
Azad, Arun A. ;
Nykter, Matti ;
Gleave, Martin E. ;
Wyatt, Alexander W. ;
Chi, Kim N. .
CANCER DISCOVERY, 2018, 8 (04) :444-457
[5]   Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Luber, Brandon ;
Liang, Chao ;
Wang, Hao ;
Chen, Yan ;
Silberstein, John L. ;
Piana, Danilo ;
Lai, Zhao ;
Chen, Yidong ;
Isaacs, William B. ;
Luo, Jun .
EUROPEAN UROLOGY, 2018, 74 (02) :218-225
[6]   Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration- Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Luber, Brandon ;
Wang, Hao ;
Chen, Yan ;
Zhu, Yezi ;
Silberstein, John L. ;
Taylor, Maritza N. ;
Maughan, Benjamin L. ;
Denmeade, Samuel R. ;
Pienta, Kenneth J. ;
Paller, Channing J. ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Luo, Jun .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2149-+
[7]   Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Luber, Brandon ;
Wang, Hao ;
Chen, Yan ;
Nakazawa, Mary ;
Nadal, Rosa ;
Paller, Channing J. ;
Denmeade, Samuel R. ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Luo, Jun .
JAMA ONCOLOGY, 2015, 1 (05) :582-591
[8]   AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Wang, Hao ;
Luber, Brandon ;
Nakazawa, Mary ;
Roeser, Jeffrey C. ;
Chen, Yan ;
Mohammad, Tabrez A. ;
Chen, Yidong ;
Fedor, Helen L. ;
Lotan, Tamara L. ;
Zheng, Qizhi ;
De Marzo, Angelo M. ;
Isaacs, John T. ;
Isaacs, William B. ;
Nadal, Rosa ;
Paller, Channing J. ;
Denmeade, Samuel R. ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Luo, Jun .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :1028-1038
[9]  
Armenia J, 2019, NAT GENET, V51, P1194, DOI 10.1038/s41588-019-0451-6
[10]   Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory [J].
Arnold, Melina ;
Karim-Kos, Henrike E. ;
Coebergh, Jan Willem ;
Byrnes, Graham ;
Antilla, Ahti ;
Ferlay, Jacques ;
Renehan, Andrew G. ;
Forman, David ;
Soerjomataram, Isabelle .
EUROPEAN JOURNAL OF CANCER, 2015, 51 (09) :1164-1187